Final presentations by Jaydira Del Rivero, MD on Understanding NET Guidelines Pamela Kunz, MD, FASCO on Understanding NET Clinical Trials & Live Q&A Watch here: lacnets.org/2024conference CarcinoidCancer CCF NET Research Foundation NET Cancer Day Healing NET NANETS #LetsTalkAboutNETs Josh Mailman

Dr. Jaydira Del Rivero, MD sabe mucho sobre el tema de los tumores neuroendocrinos, especialmente la enfermedad #feo #pheo #para. 👏❤️🔬 NETs México

TODAY at 1 pm EST!!! 👇👇👇👇🦓🦓

Many thanks to Nitin Roper MD for giving us his time to give a fantastic presentation at this month's NETChatter. Thank you also Jaydira Del Rivero, MD for organising for Dr Roper to speak and we look forward to hearing more in the future about this great trial.

Join in a discussion of clinical trials 🔬for #pheo #para. It's a PHabulous opportunity to connect with an expert in the field. Register & submit your Qs for Dr. Jaydira Del Rivero, MD ➡️bit.ly/4czdxI7 NORD LACNETS Pheo Para Project NET Cancer Day Ronny Allan NANETS

📣Learn more about #clinicaltrials available for #pheo #para #PPGL from one of the foremost experts in this field Dr. Jaydira Del Rivero, MD. Grateful for her time & expertise! 👏❤️🔬 Register today to submit your questions in advance. ➡️bit.ly/3Scn4fT

This newly published review article summarizes the current clinical status of well-differentiated gastroenteropancreatic neuroendocrine tumors across diagnostic and treatment modalities. acsjournals.onlinelibrary.wiley.com/doi/full/10.10… Jaydira Del Rivero, MD OncoAlert

Looking for a good review on gastroenteropancreatic NET management...? Here is one just published. acsjournals.onlinelibrary.wiley.com/doi/full/10.10… Jaydira Del Rivero, MD Rachel Riechelmann Jaume Capdevila Lisa Bodei, MD, PhD Julie Hallet

Coming soon! Clinical trials🔬 are essential to the development of new diagnostic tools/therapies -- & the expanded use of those already on the market -- for those with #pheo #para. Register to submit your Qs to #NETs NIH expert Dr. Jaydira Del Rivero, MD 👏 ➡️bit.ly/4czdxI7

Next week! Clinical trials🔬 are essential to the development of new diagnostic tools/therapies -- & the expanded use of those already on the market -- for those with #pheo #para. Register to submit your Qs to #NETs NIH expert Dr. Jaydira Del Rivero, MD👏 ➡️bit.ly/4czdxI7

Speaking of #ClinicalTrials, join us next week for a session with Dr. Jaydira Del Rivero, MD -- an expert in #pheo #para #PPGL research 🔬 & patient care! 🩺 Grateful for her time & expertise! ❤️ Register 👉bit.ly/3Scn4fT National Cancer Institute NIH Clinical Center

This year’s #CEU2024 #adrenal faculty includes Christina Pamporaki; Jaydira Del Rivero, MD; Jenifer Brown, MD; Paolo Mulatero, MD; and Miguel Debono, MD, PhD. Register for our meeting today: bit.ly/3xKceXu

Want to know more about #NETs? Join NANETS in Chicago in November! We have a fun group of #NETologists to entertain you all weekend 😎 Early bird rates fly away tomorrow on august 1st.

TODAY ‼️ Clinical trials🔬 are essential to the development of new diagnostic tools/therapies -- & the expanded use of those already on the market -- for those with #pheo #para. Register to submit your Qs to #NETs NIH expert Dr. Jaydira Del Rivero, MD 👏 👉bit.ly/3Scn4fT

Excited to share our latest publication in Cancer: "Update in the Management of Gastroenteropancreatic Neuroendocrine Tumors." Explore the latest advancements in diagnosis and treatment of NETs. Jaydira Del Rivero, MD #Neuroendocrine #Oncology acsjournals.onlinelibrary.wiley.com/doi/abs/10.100…

A must attend CME Symposium in the DMV area Triparna Sen (Sen-Lab) Elad Sharon Asrar AlAhmadi, MD, MAS-CR (أسرار) Chris Draft Jaydira Del Rivero, MD Dr. Estela Rodriguez Anwaar Saeed Rafeh Naqash, MD

Recently published: A Database Tool Integrating Genomic and Pharmacologic Data from #AdrenocorticalCarcinoma (ACC) Cell Lines, PDX, and Patient Samples, by Yashuhiro Arakawa et al. bit.ly/3yPFOv9 Jaydira Del Rivero, MD NCI Center for Cancer Research #openaccess

Want to know more about alpha particle PRRT for NETs. Well, here is something for you to read... journals.lww.com/nuclearmed/ful…

🚨Awaited prospective data for neoadjuvant in PNETs BJS Single arm preop PRRT for high-risk PNET 👥31 patients ✔️59% response rate ✔️path response exists 36% fibrosis ✔️M&M profile not altered Important step forward - congrats Stefano Partelli! 📝👇🏻

Mesentery-sparing resection for small bowel #NETs : resectability is in the 👁️ of the beholder 👉🏻spare arterial branches, spare bowel length, make proximal tumors resectable, for benefit of patient outcomes & QoL 📸credit Ino De Martino